UBS Group’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-288,300
Closed -$2.29M – 9689
2023
Q3
$2.29M Buy
+288,300
New +$1.82M ﹤0.01% 3311

Other funds holding MSOS

UBS Group's MSOS Position: Q3 2026 in Review

UBS Group increased its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 1.5% in Q3 2026, buying an estimated $5.89K and bringing the position to 87,461 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #6309.

UBS Group first reported a position in MSOS in Q2 2021 and has held it in 19 quarters since. The position peaked at $2.85M in Q1 2024. 97 funds tracked by Wall St. Rank hold MSOS as of Q3 2026.

  • UBS Group held 87,461 shares of AdvisorShares Pure US Cannabis ETF worth $395K as of Q3 2026.
  • UBS Group bought 1,257 AdvisorShares Pure US Cannabis ETF shares in Q3 2026, an estimated $5.89K.
  • AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #6309 holding.
  • UBS Group first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2021 and has held it in 19 quarters since.
  • UBS Group's AdvisorShares Pure US Cannabis ETF position peaked at $2.85M in Q1 2024.
  • 97 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.